http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003525431-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-485 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-66 |
| filingDate | 2001-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2003525431-A |
| titleOfInvention | Method for identifying a medicament for treating NIDDM-diabetes by interacting with compound U0126 |
| abstract | (57) [Summary]nThe present invention identifies (i) a target polypeptide that interacts with compound U0126 (1,4-diamino-2,3-dicyano-1,4-bis [2-aminophenylthio] butadiene); (ii) Contacting the polypeptide with a candidate drug; and (iii) determining whether the candidate drug modulates the biological activity of the target polypeptide, and determining whether such modulation reduces the cellularity of glucose. Incorporation is indicative of a medicament useful for treating or preventing a medical condition associated with it: It relates to a method of identifying a medicament useful for treating or preventing a medical condition associated with reduced cellular uptake of glucose, including steps. |
| priorityDate | 2000-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 209.